Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $8.93B | 179.7x | 0.23 | $27.07 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.3% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | $2.55B | -14x | 2.28 | $2.04 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $867.65M | -19.5x | 0.5 | $2.61 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | $763.40M | -1.5x | -0.11 | $0.62 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $576.26M | -11.3x | 0.15 | $1.23 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | $400.29M | -8.5x | -0.63 | $0.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $238.64M | -1.8x | 0.07 | $0.03 | -8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $237.25M | 19.8x | 0.49 | $1.36 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | $225.02M | -9.1x | 0.2 | $0.40 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | $177.20M | -22.4x | -0.7 | $1 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $163.56M | -9.3x | -0.15 | $0.42 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $97.90M | -15.3x | -0.35 | $0.09 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $95.01M | -11.7x | 0.05 | $0.52 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $94.15M | -17.6x | -0.81 | $0.77 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | $92.81M | -3.8x | -0.37 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | $90.85M | -7.3x | -0.19 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AVITA Medical | Sydney | Healthcare | Biotechnology & Medical Research | $72.48M | -0.7x | 0.05 | $2.71 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | $63.54M | -9.5x | -3.59 | $0.49 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $49.55M | -4.5x | -0.14 | $0.22 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $49.42M | -2.3x | -0.13 | $0.009 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $47.13M | 24x | 0.21 | $0.02 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $45.13M | -8.8x | -0.2 | $0.10 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $44.67M | -2.4x | -0.45 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | $37.87M | -3.5x | -0.12 | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $32.21M | -4.6x | -0.45 | $0.04 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $31.74M | -6.2x | -1.12 | $0.17 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | $29.18M | -2.4x | 0.03 | $0.03 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $26.38M | -2.4x | 0.22 | $0.07 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Biosciences | Sydney | Healthcare | Biotechnology & Medical Research | $24.11M | -9.4x | -0.15 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | $22.96M | -13x | -0.31 | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noxopharm | Sydney | Healthcare | Biotechnology & Medical Research | $22.21M | -9.8x | -0.11 | $0.08 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avecho Bio | Sydney | Healthcare | Biotechnology & Medical Research | $19.02M | -7x | -0.18 | $0.006 | -14.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BTC Health | Sydney | Healthcare | Biotechnology & Medical Research | $16.53M | 3.9x | 0.03 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tissue Repair | Sydney | Healthcare | Biotechnology & Medical Research | $16.33M | -3.7x | 0.1 | $0.27 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emyria | Sydney | Healthcare | Biotechnology & Medical Research | $15.20M | -8.2x | -0.09 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BPH Energy Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $12.18M | 0.9x | 0 | $0.010 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Percheron Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $10.87M | -0.7x | 0.37 | $0.01 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algorae Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $8.44M | -5x | -0.14 | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chimeric Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $7.88M | -0.3x | -0.05 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invion Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $7.74M | 0.01 | $0.11 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Holista CollTech Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $7.14M | -100x | -1.04 | $0.03 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adalta | Sydney | Healthcare | Biotechnology & Medical Research | $6.31M | -1.1x | -0.04 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelira Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $5.67M | -1.2x | -0.01 | $0.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuroscientific Biopharma | Sydney | Healthcare | Biotechnology & Medical Research | $5.21M | 4.5x | 0.08 | $0.04 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cambium Bio | Sydney | Healthcare | Biotechnology & Medical Research | $4.65M | -390x | $0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Invex Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $4.51M | 49.6x | 0.39 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Patrys Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $4.11M | -1x | -0.03 | $0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vectus Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | $3.99M | -1.8x | -0.2 | $0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotron Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $2.71M | -0.04 | $0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hexima | Sydney | Healthcare | Biotechnology & Medical Research | $2.17M | -2.3x | 0.07 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |